10zyme

10zyme is engineering biology to develop an innovative diagnostic technology that will empower women to effectively control their cervical health. As an early-stage UK MedTech startup, we are pioneering a visionary approach to cervical screening. Our unique self-test will deliver instant results for high-risk HPV, the virus responsible for over 99% of all cervical cancers- 10zyme’s self-testing solution will provide immediate, reliable results wherever and whenever the test is taken. In comparison, self-collection/ sampling methods developed elsewhere only offer an alternative means of sample collection that still require transportation and laboratory testing, therefore leading to delays in obtaining results. Self-testing will significantly increase screening uptake whilst reducing strain on vital healthcare resources, providing an accessible, convenient, and life-saving cancer prevention solution to all: • Non-invasive and simple to use • Provides sensitive and accurate results compared to lab-based tests • Increases cervical screening uptake • Reduces strain on vital healthcare resources • Provides an accessible, convenient, and life-saving cancer prevention solution to all